# Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC — Form D

Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-13. The offering totals $5.0M, of which $2.2M was reported sold. Industry: Investing.

## Offering

- Filed: 2018-08-13
- Form: D
- Accession: 0001749931-18-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.2M
- Remaining: $2.8M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2018-08-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-319022

## Issuer

- Name: Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC
- CIK: 0001749931
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 300 S. WACKER DRIVE SUITE 2750, CHICAGO, IL, 60606
- Phone: 312-276-4529

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| J Patrick Barry | Executive Officer | Chicago, IL |

## More

- [CIK 1749931 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1749931&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001749931-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.